4 results
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
and Treating HHV ... Disease (MCD) in HIV-AIDS ... and uncontrolled HIV ... activity against HHV ... #management #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... in HIV-AIDS Oropharyngeal ... candida #mucosal #IDSA ... #Prevention #Treatment ... #management #opportunistic
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Avium Complex in HIV-AIDS ... Mycobacterium #AviumComplex ... #MAC #IDSA #Prevention ... #Treatment #management
IDSA Recommendations for Treating Bartonella Infections in HIV-AIDS
Preferred Therapy
For Bacillary Angiomatosis, Peliosis Hepatis, Bacteremia, and Osteomyelitis:
IDSA Recommendations ... Infections in HIV-AIDS ... Angiomatosis, Peliosis Hepatis ... #Prevention #Treatment ... #management #opportunistic